Therapy of infections in the immunocompromised host.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D006801:Humans; D007154:Immune System Diseases / Q000150:complications*; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007167:Immunotherapy; D007239:Infections / Q000150:complications / Q000628:therapy*
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000998:Antiviral Agents